NMPA Approval

Sitagliptin Phosphate/metformin Hydrochloride Tablets

Approval Number

国药准字H20253198

Company浙江永太药业有限公司

Registration Date

January 14, 2025

Drug Information

Generic Name

西格列汀二甲双胍片(Ⅰ)

Dosage Form

片剂

Strength

每片含磷酸西格列汀50mg（以C₁₆H₁₅F₆N₅O计）和盐酸二甲双胍500mg（以C₄H₁₁N₅•HCl计）。

Drug Type

化学药品

Registration Date

January 14, 2025

Company Information

Applicant Company

Company Name浙江永太药业有限公司

Company Address

浙江省化学原料药基地临海园区

Manufacturing Company

Company Name浙江永太药业有限公司

Company Address

浙江省化学原料药基地临海园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

西格列汀二甲双胍片(Ⅰ) - NMPA 批准文号 | MedPath